Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,140
-130 (-0.98%)
Jun 5, 2025, 3:30 PM KST

Oncocross Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
156,31975,179----
Enterprise Value
139,73662,376----
Last Close Price
13140.006340.00----
PS Ratio
145.5170.12----
PB Ratio
8.533.68----
P/TBV Ratio
8.553.68----
EV/Sales Ratio
130.0758.18----
Debt / Equity Ratio
0.020.030.010.050.20-1.14
Asset Turnover
0.060.050.010.010.01-
Quick Ratio
16.9011.3515.164.477.871.05
Current Ratio
17.1811.4215.254.597.931.06
Return on Equity (ROE)
-43.44%-35.10%-36.33%-114.08%--
Return on Assets (ROA)
-27.25%-21.69%-32.76%-53.18%-27.13%-
Return on Capital (ROIC)
-28.49%-23.15%-36.02%-61.28%-60.40%-
Earnings Yield
-4.65%-8.62%----
FCF Yield
-5.06%-7.56%----
Buyback Yield / Dilution
-16.54%-17.49%-1.44%-63.74%-0.83%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.